The ASC leadership and its membership is committed to supporting women’s health and working collaboratively with other pathology and clinical professionals to effectively prevent cervical cancer in the United States.
Primary screening with HPV is now one of three currently available test options for cervical cancer screening. We can best serve our patients by:
a) Understanding the value, as well as, the limitations of various testing options available for cervical cancer screening.
b) Offering clinically validated testing with adequate quality control in our laboratories.
c) Keep abreast of the current published scientific data so that we are able to effectively communicate with our clinical colleagues and other professional organizations.